Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH

极端 pH 条件下连续流动、不含两性电解质的基于 pI 的分选肽/蛋白质

基本信息

  • 批准号:
    7788037
  • 负责人:
  • 金额:
    $ 23.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-01 至 2011-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In view of the complexity of the expressed proteome in a given cell type, tissue, or organism, proper sample preparation is absolutely critical for subsequent analysis by 2D gel electrophoresis or mass spectrometry. The isoelectric focusing (IEF), with its high resolving power, is one of the most common techniques used for sample preparation. IEF allows a fractionation of a complex sample based on the isoelectric points (pI) of the proteins. The pH gradient necessary for pI-based fractionation is generated either by carrier ampholytes or by immobilized IPG gels. In this project, we propose a novel continuous-flow, ampholyte-free pI-based sorting technique based on free-flow zone electrophoresis that can fractionate complex proteins/peptides only using a common buffer solution. Instead of generating a broad pH gradient and performing a parallel fractionation in a single step, as is the case with the current ampholyte- or gel-based IEF techniques, the sample mixture is sequentially titrated down inside the microfluidic channel and fractionated into a specific pI range after each sorting step. The sequential sorting scheme works in continuous-processing mode and can achieve a high throughput with a flow rate of 1-5 5L/min that allows processing a sample volume up to 100 5L within half an hour. The required electric field is supplied from an external power source through a robust self-assembled bead membrane. For the sake of simplicity in the device fabrication and operation, we propose to couple just two sorting steps in a single chip and aim at a very narrow pI range isolation/extraction of molecules, the range as narrow as d 0.5 pH units, from complex samples in pH 3-10 range as well as beyond pH range. Since the pI range is freely adjustable by the titration in a micromixer, we can achieve a narrow pI range isolation in the acidic and, more importantly, in the basic range where the conventional IPG offers only broad range strips (e pH 3.0 units). This continuous-flow sorting technique will offer a new possibility to extend the current pH range to extremely acidic (pH < 3) or basic conditions (pH > 10), a terra incognita due to the limited pH capability of the ampholyte- and gel-based IEF techniques. A successful implementation of this project will result in a simple and downstream- compatible microfluidic sorting device that will enable an automatic, ampholyte- and gel-free, pI-based sample fractionation of proteins and peptides into a very narrow pI range (d 0.5 pH units), even at extreme pH conditions, in a high-throughput mode to accommodate the needs of targeted proteomics. Combined with RP- LC, it will offer a powerful multidimensional separation for MS analysis. It will open up a new, exciting opportunity to detect proteins and peptides at extreme pH values. Some of them might be related to human diseases such as gastric carcinoma or brain diseases. Thus, this new tool can improve the detection of diseases and help to find better treatment which is within the scope of the mission of NIBIB. PUBLIC HEALTH RELEVANCE: The goal of this project is to develop a microfluidic pI-based sorting device which allows a continuous-flow and high-throughput fractionation of complex protein/peptide mixtures. This device will enable the fast detection and identification of proteins that are related to certain human diseases.
描述(由申请人提供):鉴于给定细胞类型、组织或生物体中表达的蛋白质组的复杂性,适当的样品制备对于随后通过2D凝胶电泳或质谱法进行分析绝对至关重要。等电聚焦(IEF)具有高分辨率,是最常用的样品制备技术之一。IEF允许基于蛋白质的等电点(pI)对复杂样品进行分级。基于pI的分级分离所需的pH梯度通过载体两性电解质或通过固定化IPG凝胶产生。在这个项目中,我们提出了一种新的连续流动,两性电解质免费PI为基础的分选技术的基础上自由流动区带电泳,可以fractionalize复杂的蛋白质/肽只使用一个共同的缓冲溶液。与当前基于两性电解质或凝胶的IEF技术的情况不同,在单个步骤中产生宽pH梯度并进行平行分级,样品混合物在微流体通道内依次向下滴定,并在每个分选步骤后分级至特定的pI范围。顺序分选方案在连续处理模式下工作,并且可以在1-5 5L/min的流速下实现高通量,允许在半小时内处理高达100 5L的样品体积。所需的电场由外部电源通过坚固的自组装珠膜提供。为了简化设备的制造和操作,我们建议在一个单一的芯片耦合只有两个分选步骤,并针对一个非常窄的pI范围的分子分离/提取,范围窄至d 0.5 pH单位,从复杂的样品在pH 3-10的范围,以及超出pH范围。由于pI范围可通过微混合器中的滴定自由调节,因此我们可以在酸性范围内实现窄pI范围分离,更重要的是,在碱性范围内,传统IPG仅提供宽范围条带(例如pH 3.0单位)。这种连续流分选技术将提供一种新的可能性,将当前的pH范围扩展到极端酸性(pH < 3)或碱性条件(pH > 10),由于两性电解质和基于凝胶的IEF技术的有限pH能力,这是一个未知的领域。该项目的成功实施将产生简单且下游兼容的微流体分选装置,其将能够以高通量模式将蛋白质和肽自动、无两性电解质和凝胶、基于pI的样品分级分离成非常窄的pI范围(d 0.5 pH单位),即使在极端pH条件下,以适应靶向蛋白质组学的需要。与RP-LC联用,将为MS分析提供强大的多维分离.这将为在极端pH值下检测蛋白质和肽开辟一个新的、令人兴奋的机会。其中一些可能与人类疾病如胃癌或脑疾病有关。因此,这一新工具可以改善疾病的检测,并有助于找到更好的治疗方法,这属于NIBIB的使命范围。 公共卫生关系:该项目的目标是开发一种基于PI的微流体分选装置,该装置允许复杂蛋白质/肽混合物的连续流动和高通量分级。该设备将能够快速检测和识别与某些人类疾病相关的蛋白质。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONGYOON HAN其他文献

JONGYOON HAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONGYOON HAN', 18)}}的其他基金

Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells
利用宿主细胞无膜灌注培养连续生产病毒载体
  • 批准号:
    10414312
  • 财政年份:
    2021
  • 资助金额:
    $ 23.03万
  • 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
  • 批准号:
    10201300
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
  • 批准号:
    10474343
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
  • 批准号:
    10263273
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Novel Process Analytic Technology for Continuous Bioprocessses
用于连续生物过程的新型过程分析技术
  • 批准号:
    9929893
  • 财政年份:
    2019
  • 资助金额:
    $ 23.03万
  • 项目类别:
Novel Process Analytic Technology for Continuous Bioprocessses
用于连续生物过程的新型过程分析技术
  • 批准号:
    10238815
  • 财政年份:
    2019
  • 资助金额:
    $ 23.03万
  • 项目类别:
Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH
极端 pH 条件下连续流动、不含两性电解质的基于 pI 的分选肽/蛋白质
  • 批准号:
    8010211
  • 财政年份:
    2010
  • 资助金额:
    $ 23.03万
  • 项目类别:
PROJECT 10
项目10
  • 批准号:
    7695182
  • 财政年份:
    2008
  • 资助金额:
    $ 23.03万
  • 项目类别:
Nanofluidic Tools for Proteomic Sample Preparation
用于蛋白质组样品制备的纳米流体工具
  • 批准号:
    7237946
  • 财政年份:
    2005
  • 资助金额:
    $ 23.03万
  • 项目类别:
Nanofluidic Tools for Proteomic Sample Preparation
用于蛋白质组样品制备的纳米流体工具
  • 批准号:
    7121548
  • 财政年份:
    2005
  • 资助金额:
    $ 23.03万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了